Absence of inhibitory tumor metabolism: high serum lactate dehydrogenase concentrations correlate with poor outcome to anti-CTLA-4 and anti-PD-1 antibody immunotherapy [177]. This evidence concerns the gene CTLA4 and neoplasm.